LINNEA CONGDON: Open Payments
NPI 1861134868 · GREENE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,511 in 101 payments from 14 companies in 2025. Trend: 2023 $1,522 · 2024 $1,824 · 2025 $2,511
Food & beverage: $2,511
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $587 |
| Novo Nordisk Inc | 20 | $553 |
| ABBVIE INC. | 17 | $375 |
| GlaxoSmithKline, LLC. | 19 | $289 |
| Exact Sciences Corporation | 11 | $257 |
| Lilly USA, LLC | 4 | $96 |
| Phathom Pharmaceuticals, Inc. | 4 | $70 |
| Axsome Therapeutics, Inc. | 3 | $62 |
| Amgen Inc. | 3 | $52 |
| Verona Pharma, Inc. | 2 | $49 |
Products named: Ozempic, TRELEGY ELLIPTA, FARXIGA, BREZTRI, VRAYLAR, AIRSUPRA, Wegovy, UBRELVY.
Industry payments across NY — which companies pay providers there.
